BioNTech SE (BNTX) Change in Intangibles (2024 - 2025)
BioNTech SE (BNTX) posted Change in Intangibles of $1.3 million for Q4 2025, up 140.57% on a QoQ basis from -$3.2 million in Q3 2025, and up 104.89% year-over-year from $624941.5 in Q4 2024.
BioNTech SE (BNTX) has 2 years of Change in Intangibles data on file, last reported at $1.3 million in Q4 2025.
- In Q4 2025, Change in Intangibles rose 104.89% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at -$31.6 million (changed N/A YoY), while the FY2025 annual figure was -$648.4 million, down 265.97% from the prior year.
- Change in Intangibles climbed to $1.3 million in Q4 2025, from -$3.2 million in the prior quarter.
- Across five years, Change in Intangibles topped out at $1.3 million in Q4 2025 and bottomed at -$56.8 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | -3.16 Mn |
| Sep 30, 2025 | -3.16 Mn |
| Jun 30, 2025 | -3.51 Mn |
| Jun 30, 2025 | -3.51 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Dec 31, 2024 | -26.18 Mn |
| Sep 30, 2024 | -11.20 Mn |
| Sep 30, 2024 | -11.20 Mn |
| Jun 30, 2024 | -56.75 Mn |
| Jun 30, 2024 | -56.75 Mn |